Literature DB >> 9780195

Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.

Y Kang1, P A Calvo, T M Daly, C A Long.   

Abstract

Immunization with DNA vaccines encoding relevant Ags can induce not only cell-mediated immune response but also humoral immune responses against pathogenic microorganisms in several animal models. Our previous results demonstrated that, when the C terminus (PyC2) of Plasmodium yoelii merozoite surface protein-1 (MSP-1), a leading vaccine candidate against erythrocytic stages of malaria, was expressed as a fusion protein (GST-PyC2) with glutathione S-transferase (GST), it elicited Ab-mediated protective immune responses in BALB/c mice. In our present study, we wished to examine the humoral responses to a DNA vaccine (V3) encoding GST-PyC2. The GST-PyC2 expressed in V3-transfected Cos 7 cells was recognized by a protective monoclonal Ab to PyC2 (mAb302), although the secreted product had undergone N-linked glycosylation. When BALB/c mice were immunized with V3 plasmid, anti-PyC2 Abs were successfully induced. These Abs immunoprecipitated native PyMSP-1 protein and competed with mAb302 for binding to its epitope at a level similar to those elicited by GST-PyC2 protein immunization. However, these Abs had significantly lower titers and avidities, and different isotype profiles and protective capacities against a lethal erythrocytic stage challenge, than those resulting from immunization with GST-PyC2 protein. Most surprising was the finding that, in contrast to protein immunization, there was no significant increase in the avidity of either GST-specific or PyC2-specific IgG Abs during the course of DNA immunization. This suggests that there may be little or no affinity maturation of specific Abs during DNA immunization in this system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infection.

Authors:  G Wunderlich; I C Moura; H A del Portillo
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.

Authors:  J P Sauzet; B L Perlaza; K Brahimi; P Daubersies; P Druilhe
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.

Authors:  Aneesh Vijayan; Carmen E Gómez; Diego A Espinosa; Alan G Goodman; Lucas Sanchez-Sampedro; Carlos Oscar S Sorzano; Fidel Zavala; Mariano Esteban
Journal:  J Immunol       Date:  2012-05-21       Impact factor: 5.422

4.  Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.

Authors:  A Tanghe; S D'Souza; V Rosseels; O Denis; T H Ottenhoff; W Dalemans; C Wheeler; K Huygen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.

Authors:  Bao-Xi Qu; Doris Lambracht-Washington; Min Fu; Todd N Eagar; Olaf Stüve; Roger N Rosenberg
Journal:  Vaccine       Date:  2010-06-04       Impact factor: 3.641

6.  Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.

Authors:  Yuko Kawabata; Heiichiro Udono; Kiri Honma; Masakatsu Ueda; Hiroshi Mukae; Jun-Ichi Kadota; Shigeru Kohno; Katsuyuki Yui
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.

Authors:  Balwan Singh; Monica Cabrera-Mora; Jianlin Jiang; Mary Galinski; Alberto Moreno
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

8.  Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection.

Authors:  A Haque; N Rachinel; M R Quddus; S Haque; L H Kasper; E Usherwood
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

9.  Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).

Authors:  N Ahlborg; I T Ling; A A Holder; E M Riley
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

10.  Evaluation of the immune responses induced by four targeted DNA vaccines encoding the juvenile liver fluke antigen, cathepsin B in a mouse model.

Authors:  Rama Jayaraj; David Piedrafita; Terry Spithill; Peter Smooker
Journal:  Genet Vaccines Ther       Date:  2012-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.